MRK vs ROP · P/E 33, rev $65.01B vs P/E 41, rev $1.88B
Merck & Company Inc (MRK) versus Roper Technologies, Inc. (ROP) — a side-by-side from cached financials, not a winner call.
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Rob Davis.
Roper Technologies, Inc. (ROP) is a software - application company listed on US.
Latest reported MRK revenue for 2025-12-31 was $65.01B. Net income was $18.25B. Revenue was up 1.3% from 2024-12-31 to 2025-12-31. MRK currently screens at market cap $285.12B and trailing P/E 32.5.
Latest reported ROP revenue for 2024-12-31 was $1.88B. Net income was $462.3M. Revenue was up 6.4% from 2024-09-30 to 2024-12-31. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
MRK currently screens at market cap $285.12B and trailing P/E 32.5. ROP currently screens at market cap $61.61B and trailing P/E 41.3.
Not investment advice. Open the MRK and ROP stock pages for the full models.
Not investment advice.